Tianeptine, first developed as the mood-boosting drug in Europe , has sparked considerable debate internationally. Unlike most antidepressants which act by increasing serotonin levels, tianeptine suggests to improve serotonin transport and impacts glutamate , resulting in atypical responses. Its